No Detail Found!

Comparison of Efficacy of Metformin and Insulin in management of Gestational Diabetes. An experience in Social Security Teaching Hospital, Ferozepur Road Lahore

Author(s)
ASMA SARWAT Department of Gynecology, Punjab Employees Social Security Institution Lahore,Pakistan
NAJMA PERVEEN Department of Gynecology, Punjab Employees Social Security Institution Lahore,Pakistan
AMINA SALEEMl Department of Gynecology, University College of Medicine and Dentistry Lahore,Pakistan
FAISAL REHMAN Punjab Employees Social security Institution Lahore.Pakistan
IQRA ZAFAR Department of Gynecology, Punjab Employees Social security Institution Lahore.Pakistan
GHAZALA IFTIKHAR Department of Gynecology, Punjab Employees Social security Institution Lahore.Pakistan
Abstract
To compare the feto-maternal outcomes in patients receiving metformin with those receiving standard insulin therapy for management of gestational diabetes mellitus (GDM). Methods: This randomized control study was conducted in gynecology unit of Social security Teaching Hospital, Ferozepur Road Lahore from January-2021 to December-2021. We included patients of GDM who needed pharmacologic intervention. In group M; Metformin was administered at a dose of 500mg twice daily for the first week, followed by an increase to a maximum dose of 2500mg daily in divided doses until the goal glycemic control was reached. In group I patients, regular insulin (Humulin R) was prescribed three times a day before each meal, with a single dose of intermediate acting insulin (NPH) given at bedtime. The primary study outcomes were birth weight, APGAR score, pre-term birth and maternal HBA1c levels before birth. Results: Maternal HbA1c levels before birth were 6.1±1.1 in group M and 6.0±1.2 in group I (p-value 0.66). The mean gestational age at birth was 37.9±1.1 weeks in group M and was 37.1±1.0 weeks in group I (p-value 0.0002). The frequency of pre-term was high in group I (16%) in comparison to only 6.0% in group M, but with insignificant p-value 0.11. The mean birth weight was 2.9±0.5 Kg in group M and 3.0±0.6 kg in group I (p-value 0.36). Conclusion: Better maternal glycemic control has been linked to the usage of metformin during pregnancy. In terms of patient compliance, the medicine is well tolerated. Patients with gestational diabetes mellitus who took Metformin experienced fewer neonatal problems than those who used insulin.
Publication Details
Page(s) 242-244
Published Journal: Pakistan Journal of Medical and Health Sciences, Volume: 16, Issue: 05, Year: 2022

Request the full text from PASTIC

Keywords
Insulin, gestational diabetes mellitus, metformin
References
Mack LR,Tomich PG,Care Clinical .2017 .. Obstet Gynecol Clin North Am, 44(2) : 207-217.
Johns EC,Denison FC,Norman JE,Reynolds RM,Complications RM .2018 .. Trends Endocrinol Metab, 29(11) : 743-754.
. .. 2014. Diabetes Care. 2014 Jan;37 Suppl, 1 : S14-80.
Lewandowska M,Więckowska B,Sajdak S.,Pre-Pregnancy Obesity .1980 .Excessive Gestational Weight Gain, and the Risk of PregnancyInduced Hypertension and Gestational Diabetes Mellitus. 2020 Jun, 24(6) : .
Cosson E,Cussac-Pillegand C,Benbara A .2016 .Pregnancy adverse outcomes related to pregravid body mass index and gestational weight gain, according to the presence or not of gestational diabetes mellitus: a retrospective observational study. Diabetes Metab, 42(1) : 38-46.
Esakof T,Cheng Y,Sparks T,Caughey A .2009 .The association between birthweight 4000 g or greater and perinatal outcomes in patients with and without gestational diabetes mellitus. Am J Obstet Gynecol, 200(6) : 672-4.
Vohr B,Boney C .2008 .Gestational diabetes: the forerunner for the development of maternal and childhood obesity and metabolic syndrome. J Matern Fetal Neonatal Med, 21(3) : 149-57.
Alfadhli E. .2015 .Gestational diabetes mellitus. Saudi Med, 36(4) : 399-406.
Pintaudi B,Bonomo MA .2020 .Pharmacological treatment of gestational diabetes mellitus: when lifestyle intervention is not enough. In Gestational Diabetes. Karger Publishers, : 61-75.
Wensel T. .2009 .Role of metformin in the treatment of gestational diabetes. Ann Pharmacother, 43(5) : 939-43.
Rowan J,Rush E,Obolonkin V,Battin M,Wouldes T,Hague W. .2011 .Metformin in gestational diabetes: the ofspring follow-up (MiG TOFU): body composition at 2 years of age. Diabetes Care, 34(10) : 2279-84.
Eyal S,Easterling TR,Carr D,Umans JG,Miodovnik M,Hankins GD .2010 .Pharmacokinetics of metformin during pregnancy. Drug Metab Disposition, 38(5) : 833-40.
Lee N,Hebert MF,Prasad B,Easterling TR,Kelly EJ,Unadkat JD .2013 .Effect of gestational age on mRNA and protein expression of polyspecific organic cation transporters during pregnancy. Drug Metab Disposition, 41(12) : 2225-32.
Choi K,Kim Y .2010 .Molecular mechanism of insulin resistance in obesity and type 2 diabetes. Korean J Intern Med, 25(2) : 119-29.
Rich-Edwards JW,Kleinman K,Michels KB,Stampfer MJ,Manson JE,Rexrode KM .2005 .Longitudinal study of birth weight and adult body mass index in predicting risk of coronary heart disease and stroke in women. BMJ, 330(7500) : 1115.
Hamadani A,Zahid S,Butt ZB .2017 .Metformin versus insulin treatment in gestational diabetes in pregnancy and their effects on neonatal birthweight. Pak J Med Sci, 11 : 914-6.
Lindsay R,Loeken M. .2017 .Metformin use in pregnancy: promises and uncertainties. Diabetologia, 60(9) : 1612-9.
0

Citations

0

Downloads

98

Views